More on STOK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.5 Score)

Upcoming Events

- Earnings (5/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Stoke Therapeutics Inc. (NQ:STOK)
Delayed: 35.48 +0.83 (2.40%)
Prev. Close $34.65  
Open$33.76 
52 Wk High$ 
52 Wk Low$ 
Day High$35.54 
Day Low$33.03 
P/E N/A  
EPS$ 
Volume1,833,482 

Friends, Peers and Foes (?): BIIB (more...)

Mar 4, 2026 05:05 PM The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Mar 4, 2026 04:29 PM Form 4 Stoke Therapeutics, Inc. For: Mar 02 Filed by: Krainer Adrian R.
Mar 3, 2026 04:15 PM Form 8-K Stoke Therapeutics, Inc. For: Feb 13
Mar 2, 2026 04:42 PM Form 144 Stoke Therapeutics, Inc. Filed by: Krainer Adrian R.
Feb 24, 2026 04:01 PM Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Feb 23, 2026 04:05 PM Wolfe Research Starts Stoke Therapeutics (STOK) at Outperform
Feb 19, 2026 04:26 PM Form 4 Stoke Therapeutics, Inc. For: Feb 17 Filed by: Ticho Barry
Feb 19, 2026 04:24 PM Form 4 Stoke Therapeutics, Inc. For: Feb 17 Filed by: Leggett Thomas
Feb 19, 2026 04:24 PM Form 4 Stoke Therapeutics, Inc. For: Feb 17 Filed by: SMITH IAN F
Feb 19, 2026 04:21 PM Form 4 Stoke Therapeutics, Inc. For: Feb 17 Filed by: Hoitt Jason
View All Articles

Entities mentioned with STOK

View All Entities